AI for Good: The Future of Health
Hosted June 10, 2025
How can AI transform global health? Join us for an evening spotlighting bold innovations and collaborative solutions that are advancing health equity around the world. This program featured a dynamic panel of speakers from Gates Foundation grantee organizations discussing the transformative potential of AI in global health — from accelerating drug discovery and improving diagnostics to maternal and child health breakthroughs like the PhilipsSmartSweep AI ultrasound project. Speakers included:
- David Baker, Nobel Prize in Chemistry 2024 and Director of the Institute for Protein Design, University of Washington, will explore how AI is revolutionizing drug discovery—unlocking new possibilities in medical research and accelerating the development of life-saving treatments.
- Matthew Rielly, Business Leader for Joint Ventures in Access and Obstetrics at Philips Ultrasound, will share insights on the SmartSweep AI project—an innovative tool advancing maternal health in low-resource settings.
- Bilal A. Mateen, Chief AI Officer at PATH, will highlight how AI is transforming public health systems across Africa, with real-world applications that are improving maternal and child health outcomes.
The conversation was moderated by Rachel Sibande, Senior Program Officer for Artificial Intelligence at the Gates Foundation, and explored the intersection of innovation, ethics, and equity.
Missed the event? Watch the event video
Event partners:
Ai2 (Allen Institute for AI)
Institute for Health Metrics and Evaluation (IHME)
Microsoft AI for Health
PATH
Institute for Medical Data Science (IMDS)
Meet our speakers
David Baker, Director, Institute for Protein Design
David Baker is a Nobel Prize-winning scientist, professor of biochemistry, HHMI investigator, and director of the Institute for Protein Design at the University of Washington. His lab develops software for protein design and uses it to create molecules that address challenges in medicine, technology, and sustainability. Recent work includes the development of machine learning methods for generating functional proteins.
Bilal Mateen, MBBS, MPH, PhD, Chief AI Officer at PATH.
Dr. Mateen is responsible for developing and implementing PATH’s AI strategy while overseeing a number of programs focused on developing first-in-class AI-based solutions for addressing key healthcare challenges, and regulatory system strengthening to ensure adequate safeguards for this novel technology.
Matthew Rielly, Business Leader for Joint Ventures in Access and Obstetrics at Philips Ultrasound
Matt Rielly is currently the Ventures business Leader at Philips Ultrasound. He leads a venture organization focused on executing AI programs that open new markets through strategic external partnerships. His main goal is to advance innovative approaches in ultrasound technology, enhancing healthcare accessibility and aligning with Philips’ Access to Care strategy.
Rachel Sibande, Senior Program Officer for Artificial Intelligence at the Gates Foundation
Rachel Sibande serves as Senior Program Officer, Artificial Intelligence for Africa at the Gates Foundation. She leads on the Africa AI Scaling hubs initiative, curating investments and partnerships at the intersection of Artificial Intelligence and development domains such as health, agriculture and education.
